Literature DB >> 1968252

[Treatment of Gilles de la Tourette's disease with amisulpride].

M Trillet, T Moreau, J Daléry, R de Villard, G Aimard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1968252

Source DB:  PubMed          Journal:  Presse Med        ISSN： 0755-4982            Impact factor:   1.228


× No keyword cloud information.
  5 in total

Review 1.  [The benzamides tiapride, sulpiride, and amisulpride in treatment for Tourette's syndrome].

Authors:  K R Müller-Vahl
Journal:  Nervenarzt       Date:  2007-03       Impact factor: 1.214

Review 2.  Pharmacological options for the treatment of Tourette's disorder.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  The role of atypical antipsychotics for treatment of Tourette's syndrome: an overview.

Authors:  Cathy L Budman
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

4.  European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Authors:  Veit Roessner; Kerstin J Plessen; Aribert Rothenberger; Andrea G Ludolph; Renata Rizzo; Liselotte Skov; Gerd Strand; Jeremy S Stern; Cristiano Termine; Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785

5.  Update on the role of antipsychotics in the treatment of Tourette syndrome.

Authors:  Daniel Huys; Katja Hardenacke; Pia Poppe; Christina Bartsch; Burak Baskin; Jens Kuhn
Journal:  Neuropsychiatr Dis Treat       Date:  2012-03-12       Impact factor: 2.570
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.